Top Markets
Coin of the day
Devonian Health Group Inc. Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGF
株式のランク #29819
Devonian Health Group Inc. specializes in the creation of botanical-based... Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.
株価
$7.00
最終同期: 2026-08-17
時価総額
$19.47M
変化(1日)
0.00%
変化(1年)
-35.19%
CA
取引 Devonian Health Group Inc. (DVHGF)

カテゴリー

Devonian Health Group Inc.(DVHGF)の株価履歴
終値の最高値: $7.00 (2026-08-01)

終値の最安値: $35.44 (2022-09-01)
Devonian Health Group Inc. の株価履歴(2022 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 73.19%
2025 -46.13%
2024 -38.22%
2023 -14.47%
2022 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$744.18 7.27%
CH
$1.07K -5.58%
KR